概括
高白细胞 (WBC) 计数,即使在正常范围内,也会显著增加心脏病发作和中风的风险. 这一发现表明白细胞计数是动脉样硬化疾病的重要,未充分利用的预测因素.
科学领域:
- 心血管医学 心血管医学
- 血液学 血液学 血液学
- 流行病学 流行病学
背景情况:
- 目前的动脉样硬化风险预测模型是不完整的.
- 白血细胞 (WBC) 计数是潜在的,未被认可的心血管事件的预测因素.
- 升高的白细胞计数与心肌梗塞和中风的风险增加相关.
研究的目的:
- 调查白细胞计数与动脉样硬化疾病风险之间的关联.
- 探索WBC计数作为心血管事件预测因素的潜力.
主要方法:
- 对白细胞计数的流行病学分析与心肌梗塞和中风风险有关.
- 检查高正常白细胞计数与心血管事件风险之间的相关性.
- 考虑中性粒细胞计数作为与风险相关的特定白血细胞类型.
主要成果:
- 高正常白细胞计数 (>9000/microL) 的个体与低正常计数 (<6000/microL) 的个体相比,患急性心肌梗塞的风险大约是急性心肌梗塞的四倍.
- 烟草吸烟只能解释50%-65%的过度风险,这表明其他因素也参与其中.
- 高的白细胞计数也预测了再发病和住院死亡率的风险增加.
结论:
- 白细胞计数,特别是中性粒细胞计数,是动脉样硬化疾病风险的重要预测指标.
- 白血球细胞影响血液类风湿学,并导致内皮损伤,解释了它们的预测价值.
- 未来的研究可能通过结合白细胞激活标志物来完善风险预测.
相关概念视频
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Structure and Function of Leukocytes
An adult in good health typically has between 4,500 and 11,000 leukocytes, or white blood cells, per microliter of blood, which constitutes about 1% of the total blood volume. Unlike red blood cells, white blood cells contain a nucleus and other cellular organelles but do not have hemoglobin. Most white blood cells reside in connective tissues, particularly in lymphatic organs such as the lymph nodes, with only a small fraction present in circulating blood.
White blood cells protect the body...
White blood cells protect the body...
Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...


